Dr. Chinazo Cunningham is the principal investigator in a potentially groundbreaking study into whether marijuana use could reduce the need for addictive opioids in pain management. It’s a rare opportunity given the federal restrictions on studying marijuana. Since 1970, it’s been listed as a Schedule I drug, meaning it has no medical use and there is a high potential for abuse. Despite 30 states legalizing medical marijuana, the federal government maintains there’s not enough research to suggest it has medical benefits, and this position keeps pot from being studied by researchers. Dr. Cunningham joins Soledad O’Brien to talk about her study and the Catch-22 of studying marijuana in the U.S.
Searching for “Forgotten America”
November 26, 2016Searching for “Forgotten America”
November 26, 2016
Shortage of Home Care Workers Worries Aging Americans
June 5, 2023Shortage of Home Care Workers Worries Aging Americans
June 5, 2023
April 29, 2023
April 30, 2023April 29, 2023
April 30, 2023
School Protects Students from Lunch Debt after Federal Program ends
April 16, 2023School Protects Students from Lunch Debt after Federal Program ends
April 16, 2023
AUGUST 13, 2022
August 14, 2022AUGUST 13, 2022
August 14, 2022
Hood Medicine Initiative Aims to Dispel Health Misinformation
August 14, 2022Hood Medicine Initiative Aims to Dispel Health Misinformation
August 14, 2022
End of the Pandemic or The Start of Something Else?
January 16, 2022End of the Pandemic or The Start of Something Else?
January 16, 2022
How West Virginia Went From First to the Bottom in Vaccination Rates
December 5, 2021How West Virginia Went From First to the Bottom in Vaccination Rates
December 5, 2021